CNBS

Amplify Seymour Cannabis ETF

$20.65
+0.00%
Market closed. Last update: 10:56 PM ET

📎 Investment Objective

The Amplify Seymour Cannabis ETF (CNBS) seeks to provide investment results that correspond generally to the performance of the Amplify Seymour Cannabis Index, which is designed to provide exposure to the global cannabis industry.

Overview

ETF tracking Amplify Seymour Cannabis ETF

Category Other
Issuer Other
Inception Date 2019-07-23
Market Cap $79.2M
Average Volume N/A
Dividend Yield 4.32%
52-Week Range $13.96 - $40.74
VWAP $22.51

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The Amplify Seymour Cannabis ETF (CNBS) seeks to provide investment results that correspond generally to the performance of the Amplify Seymour Cannabis Index, which is designed to provide exposure to the global cannabis industry.

🎯 Investment Strategy

The ETF invests in a portfolio of companies that are substantially focused on or connected to the cannabis or hemp industry, including companies involved in the legal production, growth, and distribution of cannabis, cannabis-related products, and pharmaceutical applications of cannabis.

✨ Key Features

  • Provides exposure to the global cannabis industry through a diversified portfolio of companies
  • Tracks the Amplify Seymour Cannabis Index, which is designed to capture the growth potential of the cannabis sector
  • Actively managed by Amplify Investments, a leading provider of innovative ETF solutions
  • Relatively new fund with limited performance history

⚠️ Primary Risks

  • Investing in the cannabis industry carries significant risks due to the evolving regulatory environment and market volatility
  • The fund's performance is dependent on the success of the underlying companies, which may be affected by factors such as changing consumer preferences and technological advancements
  • As a relatively new fund, CNBS may have limited liquidity and trading volume compared to more established ETFs
  • The fund's concentration in the cannabis industry may result in higher volatility and risk compared to more diversified investments

👤 Best For

CNBS may be suitable for investors with a high-risk tolerance who are seeking exposure to the growth potential of the global cannabis industry. However, due to the fund's limited performance history and the inherent risks of the cannabis sector, it may not be appropriate for all investors. Investors should carefully consider their investment objectives, risk tolerance, and time horizon before investing in this ETF.